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Jak3 Is Associated with CD40 and Is Critical
for CD40 Induction of Gene Expression in B Cells
Silva H. Hanissian and Raif S. Geha signaling pathways. Four intracellular proteins that be-
long to the family of TNFR-associated factors (TRAFs),Division of Immunology
Children's Hospital and Department of Pediatrics TRAF2, TRAF3, TRAF5, and TRAF6, were found to asso-
ciate with the cytoplasmic domain of CD40 (Cheng etHarvard Medical School
Boston, Massachusetts 02115 al., 1995; Ishida et al., 1996a, 1996b; Mosialos et al.,
1995; Nakano et al., 1996). TRAF2, TRAF5, and TRAF6
were shown to mediate activation of NF-kB (Ishida et
al., 1996a, 1996b; Nakano et al., 1996; Rothe et al., 1995),
Summary whereas the function of TRAF3 is not known (Cheng et
al., 1995). Engagement of CD40 activates protein tyro-
CD40 is a receptor that is critical for the survival, sine kinases (PTKs) and serine/threonine kinases (Faris
growth, differentiation, and isotype switching of B lym- et al., 1994; Ren et al., 1994; Uckun et al., 1990), and
phocytes. Although CD40 lacks intrinsic tyrosine ki- PTKs play an important role in CD40-mediated aggre-
nase activity, its ligation induces protein tyrosine gation, (LT-a) expression, and immunoglobulin class
phosphorylation, which is necessary for several CD40- switching (Loh et al., 1995; Worm and Geha, 1995). How-
mediated events. We show that engagement of CD40 ever, CD40 lacks intrinsic tyrosine kinase activity and a
induces tyrosine phosphorylation and activation of CD40-associated PTK remains to be identified. Previous
Jak3 as well as of STAT3. Jak3 is constitutively associ- studies have shown that CD40 ligation results in the
ated with CD40, and this interaction requires a proline- rapid tyrosine phosphorylation and activation of the src
rich sequence in the membrane-proximal region of family PTKs Lyn and Syk, and of PLC-g2 (Faris et al.,
CD40. Deletion of this sequence abolishes thecapacity 1994; Ren et al., 1994). However, there has been no
of CD40 to induce expression of CD23, ICAM-1, and demonstration of direct or indirect association of src
lymphotoxin-a genes in B cells. These results indicate family kinases with CD40.
that signaling through Jak3 is activated by CD40 and A number of receptors, such as those of the cytokine
plays an important role in CD40-mediated functions. receptor superfamily, lack obvious catalytic domains in
their cytoplasmic regions. However, ligand binding to
these receptors initiates a protein tyrosine phosphoryla-Introduction
tion cascade and intracellular signaling by activating
members of the Janus kinase (Jak) family of receptor-CD40 is a B cell receptor and a member of the tumor
associated tyrosine kinases. These kinases are constitu-necrosis factor receptor (TNFR) superfamily of surface
tively associated with the membrane-proximal portionsmolecules (Banchereau et al., 1994). Signaling through
of cytokine receptor cytoplasmic domains and becomeCD40 promotes B cell growth, survival, and differentia-
activated upon ligand-induced receptor homodimeriza-tion, rescues B cells from apoptosis induced by Fas
tion or heterodimerization (Darnell et al., 1994; Ihle et(CD95) or by surface immunoglobulin M (IgM) cross-
al., 1995; Quelle et al., 1994; Stahl and Yancopoulos,linking (Clark and Ledbetter, 1994; Lederman et al., 1993;
1993). The activated Jaks phosphorylate both them-Noelle et al., 1992), induces homotypic B cell adhesion
selves and other substrates, including members of a(Kansas and Tedder, 1991), up-regulates B cell expres-
family of signal transducers and activators of transcrip-sion of B7 (CD80) (Ranheim and Kipps, 1993), Fas
tion, termed STATs, which then dimerize and translocate(Rothstein et al., 1995; Schattner et al., 1995), ICAM-1
to the nucleus where they transactivate the promoters(Barrett et al., 1991), CD23, and lymphotoxin-a (LT-a)
of cytokine-responsive genes containing the interferon(Worm and Geha, 1994), and most importantly induces
g (IFNg) activation site (GAS), related sequences, or bothimmunoglobulin class switching (Clark and Ledbetter,
(Darnell et al., 1994; Ihle et al., 1995; Ivashkiv, 1995;1994; Lederman et al., 1993; Noelle et al., 1992). The
Quelle et al., 1994; Stahl and Yancopoulos, 1993). In thisligand for CD40, CD40L, is expressed on activated CD41
study, we demonstrate that CD40 ligation on the surfaceT lymphocytes (Armitage et al., 1992; Hollenbaugh et
of B lymphocytes leads to the tyrosine phosphorylational., 1992). The critical role of CD40±CD40L interactions
and activation of the PTK Jak3 and of STAT3. We alsoin immune function is highlighted by observations that
show that Jak3 is constitutively associated with CD40.humans with X-linked hyper-IgM syndrome (HIGMX-1),
Functional studies strongly suggest that Jak3 may bewho have a defect in CD40L, are unable to undergo
involved in CD40 induction of the expression of CD23,isotype switching in vitro and in vivo (Allen et al., 1993;
ICAM-1, and LT-a.Aruffo et al., 1993; DiSanto et al., 1993; Fuleihan et al.,
1993; Korthauer et al., 1993) and that mice with targeted
disruption of their CD40L (Xu et al., 1994) or CD40 genes Results and Discussion
(Castigli et al., 1994; Kawabe et al., 1994) fail to undergo
isotype switching and to form germinal centers in re- Jak3 Is Activated following CD40 Ligation
Previous results from our laboratory revealed that tyro-sponse to T cell±dependent antigens.
The special capacity of CD40 to trigger isotype switch- sine kinase activation was critical for several CD40-
induced events (Loh et al., 1995; Worm and Geha, 1995).ing suggests that CD40 ligation activates a unique sig-
naling pathway(s) or a unique combination of known In an attempt to identify a PTK(s) that may mediate
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Figure 1. CD40 Ligation Induces Tyrosine Phosphorylation of Jak3
(A) BJAB cells were treated for 0 or 10 min at 378C with anti-CD40
MAb or with MOPC21 IgG1control. Cell lysates were immunoprecip-
itated with either normal mouse serum (NMS) or with anti-phospho-
tyrosine MAb PY20, subjected to SDS±PAGE, transferred to nitrocel-
lulose membrane, and probed with anti-phosphotyrosine MAb and
then stripped and reprobed with rabbit anti-Jak3 antibody (B). We
used 50 million cells per point.
the unique effects of CD40, we cross-linked the CD40
molecule on the surface of the human Epstein±Barr virus
(EBV)-negative Burkitt lymphoma B cell line BJAB with
Figure 2. Jak3 Is Activated following CD40 Ligationmonoclonal antibody (MAb), and immunoprecipitated
(A) BJAB cells were stimulated as above with anti-CD40 MAb orphosphotyrosine-containing proteins from the cell ly-
MOPC21. Lysates were immunoprecipitated with anti-Jak3 or nor-sates. Several proteins were found to be specifically
mal rabbit serum (NRS) and incubated with exogenous ATP. Tyro-
phosphorylated in response to CD40 ligation (Figure 1A). sine phosphorylation was measured by immunoblotting with anti-
Included in these was a protein of z125 kDa, which we phosphotyrosine antibody.
identified as Jak3 upon Western blotting with a specific (B) The blot was stripped and reprobed with anti-Jak3 antibody.
(C) The time course of Jak3 autophosphorylation in response toantibody (Figure 1B). We failed to detect Jak1, Jak2,
CD40 ligation was measured by immunoprecipitating Jak3 from celland Tyk2 among the tyrosine-phosphorylated proteins
lysates at 0±30 min following treatment with anti-CD40 MAb andfrom anti-CD40-treated cells (data not shown).
incubation with [g-32P]ATP for 5 min at 258C. The immunoprecipitates
Further support for the involvement of Jak3 in CD40 were separated by SDS±PAGE. The gel was dried and exposed to
signaling was obtained from in vitro immune complex film to detect Jak3 autophosphorylation. We used 50 million cells
kinase assays on Jak3 immunoprecipitates. CD40 liga- per point.
tion induced an increase in the kinase activity of Jak3
as evidenced by autophosphorylation (Figure 2A). The
amount of Jak3 in the immunoprecipitates remained Jak3 Is Associated with CD40
constant following treatment with anti-CD40 (Figure 2B),
To investigate whether Jak3 is associated with CD40,
indicating that the increase in Jak3 phosphorylation
lysates of BJAB cells were subjected to immunopre-seen after CD40 ligation was not merely due to a change
cipitation with anti-CD40 MAb, followed by Westernin the amount of precipitated kinase. Immune complex
blotting with anti-Jak3 antiserum. This revealed thekinase assays on immunoprecipitates of Jak1, Jak2, and
presence of Jak3 in the anti-CD40 immunoprecipitates,Tyk2 revealed no evidence of activation of these kinases
but not in control precipitates (Figure 3A). There was nofollowing CD40 ligation (data not shown). Phosphoryla-
increase in the amount of Jak3 associated with CD40tion and activation of Jak3 following CD40 ligation was
following ligation of CD40 for 1±30 min (data not shown).not restricted to BJAB cells. Similar results were ob-
Association between Jak3 and CD40 was not restrictedtained in the Daudi and Ramos B cell lines.
to BJAB cells, but also occurred in normal tonsil B cellsThe kinetics of Jak3 autophosphorylation following
(Figure 3A).CD40 engagement revealed that this kinase was capable
We next analyzed the potential of recombinant CD40of undergoing autophosphorylation within 1 min, which
to associate with purified Jak3. For this purpose, wepeaked by 10 min and was sustained up to 30 min post-
expressed and purified the intracellular (IC) domain ofstimulation (Figure 2C). These results demonstrate that
CD40 as a fusion protein with glutathione S-transferasean early event in the CD40 signaling pathway involves
(GST) (GST±CD40IC). We then examined the binding ofthe tyrosine phosphorylation and activation of the Janus
kinase Jak3. GST±CD40IC to purified Jak3 immunoprecipitated on
CD40 Activates the Jak-STAT Signaling Pathway
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Figure 3. Jak3 Is Associated with CD40
(A) Lysates from BJAB cells or tonsil B cells were immunoprecipi-
tated with either anti-Jak3 antibody, MOPC21, or anti-CD40 MAb
and Western blotted with anti-Jak3 antibody. We used 150 million Figure 4. CD40 Box1 Domain Mediates Its Association with Jak3
cells per point.
(A) Lysates from BJAB cells were incubated with GST, GST±CD40IC,
(B) Jak3 was purified from 100 million BJAB cells by immunoprecipi-
GST±CD40 box1 mutant, or GST±CD40 Thr-234→Ala mutant fusion
tation with anti-Jak3 antibody bound to protein G±Sepharose beads.
proteins immobilized on glutathione±Sepharose beads. Eluates
Immobilized Jak3 was incubated with GST or GST±CD40IC fusion were Western blotted with anti-Jak3 antibody and then stripped and
protein. The complexes were extensively washed, subjected to reprobed with anti-TRAF3 and anti-TRAF2 antibodies, respectively.
SDS±PAGE, and Western blotted with either anti-GST MAb or anti- (B) Mapping of the Jak3-binding site in CD40. BJAB cell lysates
Jak3 antibody. Normal rabbit serum was used as a control for immu- were incubated with the indicated GST±CD40IC point mutants and
noprecipitation and did not bind to either GST or GST±CD40IC (data Western blotted with anti-Jak3 antibody.
not shown).
control or with GST±CD40IC box1 mutant (Figure 4A).protein G±Sepharose beads. Western blotting with anti-
The association of Jak3 with CD40 was specific, sinceGST MAb revealed that GST±CD40IC bound to purified
we were unable to detect Jak3 binding to GST fusionJak3 (Figure 3B). This binding was specific because GST
proteins consisting of the intracellular domains of Fas,did not bind to Jak3 (Figure 3B), and GST±CD40IC did
TNFRII, and CD30 (data not shown).not bind to protein G±Sepharose beads coated with
The TRAF family members TRAF2 and TRAF3 havenormal rabbit serum (data not shown). This suggests
been reported to associate with CD40 (Cheng et al.,that Jak3 may be directly associated with CD40.
1995; Mosialos et al., 1995). To establish the specificity
of association of the CD40 box1 motif with Jak3 andMapping of the Jak3 Interaction Site in CD40
determine whether this mutation disrupted CD40±TRAFCytokine and growth factor receptors that signal via
association, we analyzed the GST±CD40IC box1 mutantJak kinases contain in their intracellular domain motifs
precipitates for the presence of TRAF2 and TRAF3 pro-referred to as box1 and box2 (Murakami et al., 1991).
teins. TRAF2 and TRAF3 were precipitated with bothBox1 is defined as a proline-rich motif that is most criti-
the wild-type GST±CD40IC and the GST±CD40IC box1cal for stable association of Jak kinases with cytokine
mutant constructs, but not with GST alone (Figure 4A).receptors, whereas box2may play a crucial role inkinase
The amounts of TRAF2 and TRAF3 precipitated withactivation (Ihle et al., 1995; Ivashkiv, 1995). We examined
wild-type GST±CD40 and with GST±CD40 box1 mutantthe amino acid sequences of the cytoplasmic tail of
were equivalent. In six experiments, the amounts ofCD40 for such motifs. We observed the presence of
TRAF2 and TRAF3 precipitated by the GST±CD40 box1both box1 (PTNKAPHP, amino acids 202±209) and box2
mutant were 90% and 102%, respectively, of the(PVTQEDGKESR, amino acids 230±240) motifs in the
amounts precipitated by wild-type GST±CD40. This sug-membrane-proximal region of the cytoplasmic domain
gests that disruption of the box1 motif in CD40 specifi-of CD40. This suggested that Jak3 could bind to CD40
cally interferes with Jak3 binding. Interestingly, a GST±through the box1 motif of this receptor.
CD40 fusion protein with a Thr-234→Ala point mutationTo ascertain that the association between Jak3 and
not only failed to bind TRAF3, but also failed to bindCD40 occurs through the box1 motif of CD40, we used
TRAF2 as well as Jak3 (Figure 4A). This suggests thata GST±CD40IC fusion protein that we had previously
Thr-234 may play a critical role in the overall conforma-constructed as well as a GST±CD40IC mutant with a
tion of the intracellular domain of CD40 and may bedeletion of the box1 motif to immunoprecipitate mole-
involved in Jak3 binding. Furthermore, it suggests thatcules from BJAB cell lysates. Jak3 was found to precipi-
tate with the GST±CD40IC construct, but not with GST loss of function associated with this point mutation (Hu
Immunity
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Figure 5. Tyrosine Phosphorylation of STAT3
in Response to CD40 Ligation
(A) Cells were stimulated for 0 or 10 min with
anti-CD40 MAb, MOPC21 control IgG, or IL-6
(20 ng/ml). Lysates were immunoprecipitated
with anti-STAT3 antibody or NRS and immu-
noblotted with anti-phosphotyrosine anti-
body (upper panel) and then stripped and re-
probed with anti-STAT3 antibody (lower
panel).
(B) Nuclear translocation of STAT3 in re-
sponse to CD40 ligation. BJAB cells were
stimulated for the indicated times with either
anti-CD40 MAb or MOPC21. Nuclear extracts
were then prepared as described (Pine et al.,
1994). Total nuclear protein (30 mg) was sepa-
rated by SDS±PAGE, transferred to nitrocellu-
lose, and immunoblotted with anti-STAT3 an-
tiserum.
(C) CD40 engagement induces IRF-1 mRNA
expression. BJAB cells were stimulated for
the indicated times with anti-CD40 MAb or
MOPC21, and RNA was extracted from the
cells and subjected to Northern blot analysis.
We loaded 15 mg of total RNA per lane. The
blot was hybridized with IRF-1 probe, ex-
posed for 3 days (upper panel), and then
stripped and reprobed with a GAPDH probe
(lower panel). CD40 ligation induced a 3-fold
increase in IRF-1 mRNA expression as as-
sessed by PhosphorImager analysis.
et al., 1994; Stamenkovic et al., 1989) may not be simply in response to CD40 ligation in this cell line (data not
ascribed to loss of TRAF binding. shown).
Following tyrosine phosphorylation, STAT proteins di-
Fine Mapping of the Jak3 Interaction Site in CD40 merize and translocate to the nucleus, where they regu-
To map the proline residue(s) in the box1 domain of late transcription from promoters containing DNA se-
CD40 critical for its interaction with Jak3, we con- quences related to GAS sites (Ihle et al., 1995; Ivashkiv,
structed three additional CD40IC mutants, expressed 1995). We examined whether CD40 ligation could induce
them as GST fusion proteins, and studied their interac- nuclear translocation of STAT3 by incubating BJAB cells
tion with Jak3.These consisted of pointmutations where with anti-CD40 MAb and probing nuclear proteins by
one of the three prolines of the box1 motif was replaced Western blotting with anti-STAT3 antibody. CD40 liga-
with alanine (Pro-202, Pro-207, and Pro-209 of CD40). tion induced nuclear translocation of STAT3 within 15
Incubation of BJAB cell lysates with these mutants re- min following treatment with anti-CD40 MAb (Figure 5B).
vealed that the Pro-207→Ala and Pro-209→Ala mutants As reported previously (Miyazaki et al., 1994; Zhang et
completely failed to bind Jak3, whereas the Pro- al., 1995; Zhong et al., 1994), a small amount of STAT3
202→Ala mutant still bound Jak3, but much less effi- protein was present in the nuclear extracts of unstimu-
ciently than wild-type CD40 (Figure 4B). These results lated cells. These results suggest that CD40 is capable
demonstrate that each of the proline residues 207 and of activating the Jak±STAT signaling pathway, which
209 in box1 is absolutely critical for interaction with may lead to gene transcription.
Jak3.
CD40 Ligation Induces IRF-1 Gene ExpressionSTAT3 Is Activated following CD40 Ligation
The promoter of the interferon regulatory factor-1 (IRF-1)An important event in cells responding to cytokines that
gene contains GAS sequenceswith high affinity for STATactivate Jak kinases isphosphorylation of STAT proteins
binding (Ihle et al., 1995; Ivashkiv, 1995). Expression of(Ihle et al., 1995; Ivashkiv, 1995). Ligation of CD40 on
IRF-1 is induced by several cytokines including IFNa,BJAB cells induced the tyrosine phosphorylation of
IFNg, and interleukin-6 (IL-6), which activates STAT3STAT3 (Figure 5A). We could not detect tyrosine phos-
phorylation of any of the other known STAT proteins (Abdollahi et al., 1991; Pine et al., 1994; Yu-Lee et al.,
CD40 Activates the Jak-STAT Signaling Pathway
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1990). IRF-1 has been implicated to play a crucial role failed to induce CD23 and LT-a and up-regulate ICAM-1
in the CD40-positive bladder carcinoma cell line T24,in cellular proliferation and differentiation (Pine et al.,
which expresses no detectable levels of Jak3 (data not1994). Since CD40 ligation induces similar effects in B
shown).cells and activates the Jak±STAT signaling pathway,
The src family kinase Lyn has been previously shownwe sought to determine whether the IRF-1 gene was
to be activated following CD40 ligation in Daudi and Rajitranscriptionally induced upon CD40 ligation. To this
cells (Faris et al., 1994; Ren et al., 1994), as well as inend, we performed Northern blot analysis using RNA
BJAB cells (S. H. H. and R. S. G., unpublished data).prepared from BJAB cells, which were stimulated with
Lyn contains an src homology 3 domain that could po-anti-CD40 MAb and probed for IRF-1 mRNA expression.
tentially associate with the proline-rich box1 motif ofBJAB cells showed constitutive expression of IRF-1
cytokine receptors. Thus, it was important to rule outmRNA, the level of which was increased approximately
that deletion of the box1 motif in CD40 did not abro-3-fold 1 hr following CD40 ligation (Figure 5C) as as-
gate a potential association with Lyn. We performedsessed by PhosphorImager analysis. These results indi-
coprecipitation experiments, but were unable to detectcate that CD40 activation of the Jak±STAT signaling
Lyn protein in anti-CD40 MAb immunoprecipitates or inpathway may culminate in active cellular transcriptional
GST±CD40IC precipitates in lysates of BJAB cells. Thisresponses.
suggests that Lyn does not associate directly with CD40
and further demonstrates the specificity of association
of the CD40 proline-rich box1 motif with Jak3. In addi-Role of Jak3 in CD40-Mediated Functions
tion, Lyn was not detected in anti-Jak3 immunoprecipi-The importance of Jak3 in immune function was recently
tates of lysates of cells left untreated or stimulated withhighlighted by two reports describing Jak3 deficiency
anti-CD40 MAb (data not shown).in SCID patients (Macchi et al., 1995; Russell etal., 1995).
A dominant-negative TRAF3, which has the potentialThese patients lack T cells but possess circulating B
to displace the binding of both TRAF3 and TRAF2 tolymphocytes, which however function poorly. Given our
CD40 (Cheng et al., 1995; Rothe et al., 1995), was pre-observations that Jak3 is associated with CD40, we at-
viously shown to inhibit CD40-mediated expression oftempted to study the role of the Jak±STAT pathway in
CD23 but not of ICAM-1 (Cheng et al., 1995). Our dataCD40-mediated expression of CD23, ICAM-1, and LT-a
indicate that Jak3 may be necessary for the expressionin EBV-transformed B cells from a patient with Jak3
of both of these molecules, as well as of LT-a. Takendeficiency (a gift of Dr. Notarangelo), since the promot-
together these two sets of data suggest that Jak3 anders of all three of these genes contain NF-kB as well as
TRAF proteins are both critical for CD23 expressionSTAT sites (Collins et al., 1995; Richards and Katz, 1994;
while Jak3, but not TRAFs, is important for ICAM-1 ex-Voraberger et al., 1991; Worm and Geha, submitted).
pression. The requirement for Jak3 but not TRAF inHowever, these cells as well as EBV-transformed B cells
ICAM-1 expression is compatible with the demonstratedfrom normal subjects exhibited high baseline expression
critical role of the STAT site, but not the NF-kB site, inof CD23, ICAM-1, and LT-a, which could not be up-
the activation of the ICAM-1 promoter (Caldenhoven et
regulated by CD40 ligation.
al., 1994). The requirement for both Jak3 and TRAF for
Since untransformed B cells from Jak3-deficient pa-
CD23 expression raises the possibility that Jak3 may
tients were not available, we proceeded to examine the
be important for activation of the TRAF pathway. Alter-
signaling capacity of chimeric CD8/CD40 molecules natively, TRAF signaling may be independent of Jak3,
with a box1 deletion. We constructed and stably trans- but the two pathways may synergize to induce CD23
fected into BJAB cells chimeric molecules consisting of gene expression.
the extracellular domain of CD8 fused to the transmem- None of the proteins associated with CD40, including
brane and intracellular domains of wild-type CD40, Jak3, TRAF2, and TRAF3, is unique to CD40. The unique
CD40 with box 1 deletion, and CD40 Thr-234 point mu- capacity of CD40 to cause isotype switching may be due
tant. Clones exhibiting equivalent levels of surface CD8 to the activation of a unique combination of signaling
expression as assessed by fluorescence-activated cell pathways. The Jak3±STAT3 signaling pathway and the
sorting (FACS) analysis were used in these experiments. TRAF signaling pathways, which include TRAF2-medi-
Figure 6 shows that ligation of native CD40 with soluble ated activation of NF-kB and TRAF3, may synergize to
CD40L up-regulated the expression of CD23, ICAM-1, activate switch recombination. This synergy may involve
and LT-a onall transfectants. This up-regulation of CD23 possible formation of STAT3±TRAF heterodimers, par-
and ICAM-1 ranged from 3- to 6-fold, but was reproduc- ticularly since TRAF3 contains a consensus Jak phos-
ible and consistent with values reported in the literature phorylation site and could potentially heterodimerize
for the up-regulation of these molecules on transformed with STAT3 following tyrosine phosphorylation. Such a
B cells (Cheng et al., 1995; Schattner et al., 1995). Cross- heterodimer may display unique DNAbinding capability,
linking with anti-CD8 of the chimeric receptor containing and potentially regulate gene expression by binding to
wild-type CD40 induced CD23, ICAM-1, and LT-a ex- novel DNA sequences in the promoter regions of genes
pression to an extent equivalent to that observed with regulated by CD40. Studies currently in progress are
ligation of native CD40. In contrast, cross-linking of both aimed at examining the association between TRAF pro-
box1 deletion and Thr-234→Ala chimeric receptor mu- teins and STAT3 in CD40-stimulated cells.
tants failed to induce CD23, ICAM-1, or LT-a expression. In addition to induction of gene expression, CD40
These results indicate that Jak3 may play an important ligation induces B cell proliferation and, most impor-
role in mediating signal transduction via CD40. This is tantly, isotype switching. These events can only be stud-
ied in primary B cells. Experiments in which mice withfurther supported by the observation that CD40 ligation
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Figure 6. Effect of CD40 Receptor Mutations
on CD23, ICAM-1, and LT-a Up-Regulation
Chimeric molecules consisting of the extra-
cellular domain of CD8 fused to the trans-
membrane and intracellular (IC) domains of
CD40 were prepared and stably expressed
in BJAB cells. These constructs contained
either wild-type CD40IC, CD40IC box 1 dele-
tion, or CD40IC Thr-234→Ala point mutation.
Transfectants expressing equivalent levels of
these molecules were stimulated for 24 hr
with soluble CD8±CD40L or with anti-CD8
MAb, followed by surface staining with conju-
gated antibodies to CD23, ICAM-1, or LT-a.
The X axis represents the fluorescence inten-
sity in arbitrary units, and the Y axis is the
number of cells. The two overlapping solid
lines at the left of each panel represent the
isotype controls; the dotted lines are the
basal expression levels of these molecules,
and the dashed lines represent their expres-
sion levels after stimulation.
reactions of the first round of PCR was subjected to amplificationdisrupted CD40 genes are reconstituted with wild-type
with CD8 59 sense and CD40 39 antisense oligonucleotides to yieldand mutated CD40 transgenes are currently in progress
a chimeric PCR fragment encoding for a protein that consisted ofto determine the role of Jak3 and TRAF proteins inCD40-
the CD8 extracellular domain fused to the CD40 TM and IC domains:
mediated B cell proliferation and isotype switching. CD8 EC/CD40 TM plus IC. The PCR products were gel purified,
cloned in the PT7 Blue vector (Novagen), sequenced in both direc-
Experimental Procedures tions, and subcloned in the mammalian expression vector pCEP4
(Invitrogen) containing the hygromycin resistance gene. PCR-medi-
DNA Constructions ated mutagenesis was used to introduce specific mutations in the
The cytoplasmic domain of the human CD40 receptor (amino acid IC domain of CD40 of this chimeric molecule using the Stratagene
residues 196±257) was amplified from the corresponding cDNA by Quick Change kit. One consisted of a point mutation where Thr-234
PCR and cloned in-frame into the pGEX-2TK expression vector was substituted by alanine, and the second of a deletion of 8 amino
(Pharmacia) using the the BamHI and EcoRI restriction sites of CD40. acids encompassing residues 202±209 (box1 domain) of CD40. The
Expression and purification of GST fusion proteins were performed wild-type and mutant chimeric molecules cloned in pCEP4 were
essentially as described previously (Smith et al., 1990). For generat- used in transfection assays as described below. A similar strategy
ing a chimeric cDNA encoding the extracellular (EC) domain of hu- was followed in generating five specific mutations in the GST±CD40
man CD8a fused to the transmembrane (TM) and intracellular (IC) fusion protein. Two of the mutations were similar to those described
domains of human CD40, overlapping PCR fragments encom- above, namely substituting alanine for Thr-234 anddeleting the box1
passing the appropriate regions of CD8a and CD40 were annealed domain of CD40. The remaining three mutants consisted of point
in a two-step PCR. A first round of PCR was performed in two mutations where prolines 202, 207, and 209 of the box1 motif of
separate reactions. A CD8a 59 sense oligonucleotide containing a CD40 were substituted by alanines.
59 XhoI restriction site and a CD8/CD40 overlap antisense oligonu-
cleotide were used in one reaction to amplify from the pPink2-CD8a
vector (a gift of Dr. L. Clayton) the CD8 59 EC region with attached Cell Culture and Transfections
The EBV-negative human Burkitt lymphoma B cell line BJAB (a giftCD40 overlapping nucleotides. In the second reaction, the CD8/
CD40 overlap sense oligonucleotide and the CD40 39 antisense of Dr. E. Kieff) was maintained in RPMI 1640 supplemented with
L-glutamine and 10% fetal bovine serum (FBS). Transfection ofoligonucleotide were used to amplify from the PGEM-CD40 vector
the CD40 39 IC plus TM region with attached CD8 overlapping nucle- BJAB cells was achieved by electroporation at 200 V and 1180
mF, in 500 ml of RPMI containing 10% FBS. Approximately 24 hrotides. In a second round of PCR, 5% of the products from the two
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posttransfection, selection was started in culture medium supple- Northern Blot Analysis
BJAB cells were stimulated for the indicated times with anti-CD40mented with 400 mg/ml hygromycin B (Boehringer Mannheim). We
further selected resistant clones for CD8 surface expression by MAb or MOPC21, andRNA was extracted from the cells using TRIzol
reagent as described by themanufacturer (GIBCO BRL Life Technol-FACS before using them in experiments.
ogies) and subjected to Northern blot analysis. We loaded 15 mg of
total RNA per lane. IRF-1 cDNA (a gift from Dr. D. Thanos) labeledPurification of Tonsil B Cells
by random priming was used as probe. The blot was exposed forTonsillar B cells were obtained by passing tonsil specimens through
3 days and then stripped and reprobed with a GAPDH probe.a mesh and rosetting twice with 2-aminoethyl-isothiouronium-bro-
mide-treated sheep red blood cells to deplete T cells as previously
FACS Analysisdescribed (Jabara et al., 1990). We used 150 million cells for each
Transfectants expressing equivalent levels of CD8/CD40 moleculesimmunoprecipitation.
were stimulated for 24 hr with soluble CD8±CD40L as described
(Castigli et al., 1994) or with anti-CD8 MAb (Amac). The cells wereImmunoprecipitation and Western Blotting
then harvested, washed in PBS supplemented with 3% BSA andBJAB cells were serum starved in RPMI containing 1% FBS for 24
0.01% sodium azide, and resuspended in 100 ml of this buffer con-hr and then treated with 10 mg/ml anti-CD40 MAb 626.1 or with
taining 10% normalmouse serum to block nonspecific binding. TheyMOPC21 IgG1 control (Sigma) for the indicated length of time. We
were then analyzed for surface expression of CD23, ICAM-1, andused 50 million cells for each immunoprecipitation. The cells were
LT-a by the addition of conjugated MAbs and incubation for 30 minlysed for 30 min on ice in 50 mM Tris±HCl (pH 7.4), 150 mM NaCl,
on ice. The antibodiesused were anti-CD23-phycoerythrin (PE), anti-2 mM EDTA, 1% Brij-96, 30% glycerol, 10 mM NaF, 10 mM Na3P2O7,
ICAM-1±fluorescein isothiocyanate (Becton Dickinson), or anti-LT-a0.5 mM Na3VO4, 4 mM PMSF, 10 mg/ml leupeptin, and 1 mg/ml of
biotinylated (a gift from Dr. Jeff Browning, Biogen), followed byeach of the following protease inhibitors: aprotinin, pepstatin A,
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